Publications by authors named "Yasuhito Uezono"

Claim this Profile
I
Identification of a novel MIPEP splice variant with altered substrate-binding properties.
Yuina Otani, Michiya Kawarai, Masaki Kobayashi, Yuka Nozaki, Rio Uchida, Yasuhito Uezono

Biochem Biophys Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical cost of postoperative delirium after highly invasive cancer resection: a prospective cohort study.
Ryoichi Sadahiro, Riria Koyama, Aya Kuchiba, Saho Wada, Ken Shimizu, Yasuhito Uezono

Jpn J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolome Profiling of Yokukansan in Preventing Postoperative Delirium in Elderly Cancer Patients: A Reverse Translational Study.
Ryoichi Sadahiro, Katsuya Ohbuchi, Taiki Nakaya, Sei Manabe, Saho Wada, Yasuhito Uezono

Psychiatry Clin Neurosci· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gefapixant Citrate, a Selective P2X3 Receptor Antagonist, May Improve Cancer-Related Hypergeusia: A Case Report.
Satoshi Murakami, Kazutaka Yamagishi, Akira Kitani, Toru Ueta, Yasuaki Matsuura, Yasuhito Uezono

J Palliat Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TXB-001, A Newly-Developed Polymer-Conjugated Anthracycline, Alleviates Anthracycline-Induced Cardiotoxicity.
Miki Nonaka, Mikito Hirakata, Chizuka Sakai, Emi Tomikawa, Akiko Izawa, Yasuhito Uezono

Cardiovasc Toxicol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-treatment with Gabapentinoid and Japanese Herbal Medicine Goshajinkigan for CIPN is Associated with Longer Duration and Higher Dose of Chemotherapy.
Kanako Miyano, Yasuhito Uezono, Takuhiro Yamaguchi, Wataru Hashimoto, Satoshi Komoriya

Adv Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mirogabalin and pregabalin alleviate nociplastic sensitization induced by chemogenetic activation of the central amygdala neurons in rodents.
Manami Yajima, Yukari Takahashi, Yasuhito Uezono, Fusao Kato

J Pharmacol Sci· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Flavonoids and Monoterpenes from Peel Contained in Ninjinyoeito Synergistically Activate Orexin 1 Receptor: A Possible Mechanism of the Orexigenic Effects of Ninjinyoeito.
Kaori Ohshima, Kanako Miyano, Miki Nonaka, Sayaka Aiso, Mao Fukuda, Yasuhito Uezono

Biomolecules· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circadian sleep-wake rhythm reversal in mice implanted with stomach cancer cell lines.
Motohide Goto, Takashi Maruyama, Miki Nonaka, Yasuhito Uezono, Yoichi Ueta

J Physiol Sci· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Activity Relationship Study of CYM51010, an agonist for the µ-δ Opioid Receptor Heterodimer.
Ayaka Watanabe, Shuma Yamada, Haruka Yoshida, Miku Inagaki, Nao Atsumi, Yasuhito Uezono

Chem Pharm Bull (Tokyo)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Inhibition of TREK-1 K Channels via Multiple Compounds Contained in the Six Kamikihito Components, Potentially Stimulating Oxytocin Neuron Pathways.
Kanako Miyano, Miki Nonaka, Masahiro Sakamoto, Mika Murofushi, Yuki Yoshida, Yasuhito Uezono

Int J Mol Sci· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicenter Retrospective Observational Study Analyzing the Effect of Polypharmacy on Oxycodone Tolerability.
Katsuya Makihara, Yoshihiro Yamamoto, Masayuki Miyazaki, Maho Taguchi, Junya Sato, Yasuhito Uezono

J Pain Palliat Care Pharmacother· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
G protein-biased LPAR1 agonism of prototypic antidepressants: Implication in the identification of novel therapeutic target for depression.
Naoto Kajitani, Mami Okada-Tsuchioka, Asuka Inoue, Kanako Miyano, Takeshi Masuda, Yasuhito Uezono

Neuropsychopharmacology· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased pain after palliative radiotherapy: not only due to cancer progression.
Satoshi Murakami, Akira Kitani, Toru Kubota, Yasuhito Uezono

Ann Palliat Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Yasuhito Uezono

Nihon Yakurigaku Zasshi· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and outcomes of cachexia in Asia: Working Consensus Report from the Asian Working Group for Cachexia.
Hidenori Arai, Keisuke Maeda, Hidetaka Wakabayashi, Tateaki Naito, Masaaki Konishi, Yasuhito Uezono

J Cachexia Sarcopenia Muscle· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 7-Azanorbornane-Based Dual Agonists for the Delta and Kappa Opioid Receptors through an In Situ Screening Protocol.
Fumika Karaki, Taro Takamori, Koumei Kawakami, Sae Sakurai, Kyoko Hidaka, Yasuhito Uezono

Molecules· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-centre, double-blind, randomized, placebo-controlled trial to evaluate the effectiveness and safety of ramelteon for the prevention of postoperative delirium in elderly cancer patients: a study protocol for JORTC-PON2/J-SUPPORT2103/NCCH2103.
Ryoichi Sadahiro, Kotaro Hatta, Takuhiro Yamaguchi, Enokido Masanori, Yoshinobu Matsuda, Yasuhito Uezono

Jpn J Clin Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Potential of Orally Administered Rubiscolin-6.
Yusuke Karasawa, Kanako Miyano, Masahiro Yamaguchi, Miki Nonaka, Keisuke Yamaguchi, Yasuhito Uezono

Int J Mol Sci· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data-driven categorization of postoperative delirium symptoms using unsupervised machine learning.
Panyawut Sri-Iesaranusorn, Ryoichi Sadahiro, Syo Murakami, Saho Wada, Ken Shimizu, Yasuhito Uezono

Front Psychiatry· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct Profiles of Desensitization of µ-Opioid Receptors Caused by Remifentanil or Fentanyl: In Vitro Assay with Cells and Three-Dimensional Structural Analyses.
Eiko Uezono, Yusuke Mizobuchi, Kanako Miyano, Katsuya Ohbuchi, Hiroaki Murata, Yasuhito Uezono

Int J Mol Sci· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The first structure-activity relationship study of oxytocin as a positive allosteric modulator for the µ opioid receptor.
Takaaki Mizuguchi, Kanako Miyano, Risa Yamauchi, Yuki Yoshida, Hideki Takahashi, Yasuhito Uezono

Peptides· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
J-SUPPORT research policy for oral mucositis associated with cancer treatment.
Tomoya Yokota, Takao Ueno, Yoshihiko Soga, Hiroto Ishiki, Yasuhito Uezono

Cancer Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of delirium with agitation by yokukansan in older adults after cancer surgery.
Ryoichi Sadahiro, Saho Wada, Yutaka J Matsuoka, Yosuke Uchitomi, Takuhiro Yamaguchi, Yasuhito Uezono

Jpn J Clin Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Intracellular Signaling Activities of κ-Opioid Receptor Agonists, Nalfurafine Analogs; Focusing on the Selectivity of G-Protein- and β-Arrestin-Mediated Pathways.
Masahiro Yamaguchi, Kanako Miyano, Shigeto Hirayama, Yusuke Karasawa, Kaori Ohshima, Eiko Uezono, Yasuhito Uezono

Molecules· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis